Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.

These findings suggest that classic psychedelics could potentially lead to reduced sick leave and associated costs in the general population, but more research is needed to investigate potential causal pathways of classic psychedelics on sick leave and evaluate possible mechanisms.